Publications on Singapore

New Medical Device Regulations in Singapore and Hong Kong

Although geographically small, Singapore is one of Asia's wealthiest nations. With its medical device imports, strong economy, and aging population, Singapore's medical device market will continue to draw Western companies. While Singapore now has a voluntary regulatory environment, new regulations being implemented will require registering all medical devices by 2011.

ASEAN Medical Device Regulatory Integration

Navigating global regulatory markets can be a challenge, particularly when multiple countries in a region differ in their rules. Playing by a common set of rules for medtech regulation is about to get a little easier in Southeast Asia, as a group of countries prepares to unveil a more unified approach to oversight.

Updates on Singapore's Medical Device Regulations

Singapore passed the Health Products Act in February 2007. Under this Act manufacturers, dealers, importers and wholesalers of medical products will eventually require comprehensive government licensing in order to do business. The deadline for compliance is in 2009, so make sure you know the newest regulations before time runs out! Companies without the proper licensing will not be allowed to import, manufacture, or sell medical devices in Singapore.

ASEAN Medical Device Harmonization Trends

Regulatory harmonization, post-marketing surveillance schemes, and a Common Submission Dossier Template are just some of the new plans the Association of Southeast Asian Nations (ASEAN) has been working on recently. Are you aware of the newest regulations and trends in Southeast Asia? Though some of these nations' medical device regulations have been minimal or nonexistant in the past, increased regulation and rapid change are now underway.

A Regulatory Update on Asia's Smaller Medical Device Markets

When medical companies think of bringing their products to the Asian markets, they typically think of larger countries like China, Japan, or Korea first. However, other smaller Asian countries such as Singapore and Malaysia can be worthwhile destinations as well. Although they have smaller populations, these markets all have well-developed healthcare systems and are receptive to advanced products. In addition, their medical device markets are growing rapidly and, in many instances, are more easily accessible to foreign manufacturers. Before venturing into these territories, however, regulatory professionals will need to keep track of current changes to be successful. This article discusses recent regulatory developments in Singapore, Malaysia, Hong Kong, the Philippines, and Taiwan.

Sourcing Medical Devices in Asia: An Introduction

The multiple advantages of lower overhead, lower labor costs, and increasing technical capabilities are leading more medical product manufacturers to establish facilities in Asia. However, manufacturing in Asia is a more complex proposition than its reputation for cheap, reasonable-quality products might suggest. Differences in language, culture and business practices can require a significant investment of resources to achieve a productive working relationship with a medical device supplier or subcontractor.

This article will go into more detail on specific countries, such as China, India, and Singapore.

Drug and Device Markets throughout the Asian Region (PDF)

Pharmaceutical and medical device markets are expanding throughout Asia. This presentation covers the medical device and pharmaceutical markets in Taiwan, Hong Kong, Malaysia, Singapore, India and Vietnam, and provides country-specific information about drug, device and IVD regulations in these countries. Specific topics include registration, pricing and reimbursement, manufacturing and GMP, import licenses, patents, and clinical trials in these countries.

Singapore’s Pharmaceutical and Medical Device Regulatory Environment: 2005 Update

Despite the country’s small size, Singapore boasts a highly-developed economy and serves as an Asian hub for numerous medical companies. In total, Singapore’s medical device and pharmaceutical markets are estimated at over $800 million. Leading pharmaceutical companies, such as GlaxoSmithKline, Pfizer, Eli Lilly and Bristol-Myers Squibb, have established a presence in Singapore and continue to expand their facilities. Pfizer chose Singapore for its first large-scale active pharmaceutical ingredient manufacturing facility in Asia, while GlaxoSmithKline set up its first Asia region preclinical research establishment in Singapore. In response to the growth of Singapore’s medical industry, the Health Sciences Authority has been making great efforts to boost its regulatory expertise and improve the pharmaceutical and medical device regulatory environment in Singapore.

Overview of Asia, Healthcare Markets and Regulatory Issues in the Region

Despite sluggish economies in some countries, Asia still represents future growth opportunities in healthcare products. Over the next 20 years, Asian healthcare markets are expected to grow at a rate two and a half times that of the West. A rising standard of living throughout the region means patients will have the resources to acquire modern medical devices and pharmaceuticals. As the globalization of healthcare continues, regulatory practices for pharmaceuticals and medical devices will be further harmonized. This report examines emerging regulatory trends and issues in China, Japan, Hong Kong, India, Indonesia, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand.

Opportunities in the Singapore Medical Market

Singapore is one of the most technologically advanced societies among the ASEAN countries. Its extensive healthcare system, high health standards, comprehensive medical facilities and advanced medical market make the small city-state an ideal place for medical market investment. The Singapore Ministry of Health and the Singapore Economic Development Board (EDB) are responsible for the Singapore’s healthcare industries. They are working to promote Singapore as the premier regional medical center in order to attract even more foreign investors of specialized medical equipment. This article gives an overview of Singapore’s medical device market, healthcare system and the business climate for foreign medical suppliers.